U.S. Mortgage REITs Stock News

Northwest Bancshares, Inc. has now reported its Q2 2026 results, with net interest income rising to US$146.94 million and net income to US$53.55 million, alongside a quarterly cash dividend of US$0.20 per share for its 127th consecutive dividend payment. The quarter’s strong earnings beat, supported by higher net interest margin, solid loan growth, and stable credit quality, highlights operational efficiency and balance sheet resilience. Next, we’ll examine how this earnings beat and...

Fastenal Company recently reported second-quarter 2026 results showing higher sales of US$2,386.9 million and net income of US$382.8 million, alongside a new director appointment and an ESOP-related shelf registration for 8,500,000 common shares worth US$385.56 million. Together with a new cash dividend and ongoing share repurchases, these moves highlight how Fastenal is balancing employee ownership, governance refresh, and capital returns. We’ll now examine how this stronger quarterly...

Rollins, Inc. has already reported its second-quarter 2026 results, posting net income of US$143.91 million and diluted EPS of US$0.30, alongside affirming a quarterly dividend of US$0.1825 per share payable on September 10, 2026. The modest year-over-year earnings increase, combined with the maintained dividend, highlights the company’s focus on both profitability and ongoing cash returns to shareholders. With Q2 earnings showing only a slight uptick in net income, we’ll now examine how...

ON Semiconductor (ON) is back in focus as investors look ahead to its August 3 quarterly report, with expectations for higher revenue and earnings for the June 2026 period. See our latest analysis for ON Semiconductor. ON Semiconductor's share price has climbed 57.04% year to date to $89.04, while the 1 year total shareholder return of 51.79% contrasts with a 3 year total shareholder return that is down 17.36%. This suggests strong recent momentum after a weaker stretch. If ON Semiconductor's...

Legal shockwaves from Johnson & Johnson’s proposed $5.5b talc settlement are rippling through the baby care and personal health space, reshaping how investors think about litigation risk, consumer trust, and competitive positioning. With up to $3b potentially paid out in the next year and no further payments scheduled before 2028, this attempt to resolve around 69,000 talc-related lawsuits could mark a turning point for Johnson & Johnson and its peers. Below, you will see 3 stocks exposed to...

Palantir Technologies (PLTR) heads into its upcoming earnings report with expectations shaped by rising demand for its AI software, renewed U.S. government interest, and recent participation in high profile AI alliances. See our latest analysis for Palantir Technologies. Recent headlines around Palantir Technologies, from the renewed U.S. Small Business Administration fraud detection work to fresh AI alliance activity, have arrived alongside a 16.47% 30 day share price return. At the same...

Mattel (MAT) is back in the spotlight after Barbie introduced a signature doll modeled on basketball star and entrepreneur Angel Reese, paired with co-branded Reebok footwear and apparel that extends Barbie’s reach into sports culture. See our latest analysis for Mattel. Despite the recent Barbie x Angel Reese spotlight and fresh licensing moves with WWE and 7-Eleven collaborations, Mattel’s recent 1 day and 30 day share price returns of 3.21% and 5.87% sit against a year to date share price...

Recently, Ondas Holdings announced an acceleration of defense contract wins alongside a new investment in FPF Defense, which is developing autonomous counter-drone systems and relocating its headquarters to West Palm Beach to build a broader defense technology hub with Ondas. This move deepens Ondas’ exposure to autonomous defense solutions aimed at addressing cost asymmetry in drone defense, aligning closely with its existing focus on private wireless and drone technologies. We’ll now...

What Restaurant Brands International Stock Offers Investors Right Now Restaurant Brands International (NYSE:QSR) runs several large quick service restaurant chains and gives investors exposure to coffee, burgers, chicken and sandwich concepts across Canada, the United States and other international markets. The stock recently closed at US$74.41, with reported annual revenue of US$9.59b and net income of US$1.08b. This positions Restaurant Brands International as a sizeable player in global...

Grand Canyon Education (LOPE) has drawn fresh attention after recent share moves, with the stock roughly flat over the past month but down about 14% in the past 3 months. See our latest analysis for Grand Canyon Education. At a share price of $144.86, Grand Canyon Education has recently seen short term momentum pick up, with the 1 day share price return of 3.52% and 7 day share price return of 3.87% set against a weaker 1 year total shareholder return of 13.36% and stronger 3 and 5 year total...

Earlier in July 2026, Equinix, Inc. confirmed the planned departure of Chief Business Officer Jon Lin and outlined a transition plan distributing his responsibilities across the senior leadership team while preparing to appoint a new Chief Product Officer. Shortly afterward, the company named Chris Audie as Chief Product Officer and Bruce Owen as Executive Vice President, Global Markets, underscoring a sharpened focus on product innovation and global operations alignment. Next, we’ll examine...

Sarepta Therapeutics has appointed Michael Severino, M.D., a veteran of AbbVie, Amgen, Merck and most recently Tessera Therapeutics, as its Chief Executive Officer effective July 28, 2026, succeeding Douglas Ingram. By combining the CEO role with a seat on Sarepta’s board, Severino’s broad R&D and corporate strategy background could shape how the company prioritizes its gene therapy and RNA-based rare disease programs. Next, we’ll explore how bringing former AbbVie president Michael Severino...

After a 37.8% return over the past year, Best Buy stock no longer looks like an obvious bargain, and the current checks suggest pricing that is roughly in line with what its fundamentals support rather than clearly cheap or clearly expensive. The 37.8% one year gain puts recent shareholders in a strong position, which can make fresh entries more sensitive to what is already baked into the price. Leadership changes, including a new CEO and a chief fulfillment and operations officer focused on...

Rigetti Computing announced a partnership with Hewlett Packard Enterprise and the Pittsburgh Supercomputing Center to build TangleLab, a hybrid quantum‑classical supercomputing testbed at PSC, funded by a US$5.0 million National Science Foundation grant and scheduled to begin construction in 2026 with full operations targeted for 2027. This collaboration embeds Rigetti’s 9‑qubit Novera system in an open, federally backed research and education platform, potentially deepening its role in...

Earlier in July 2026, ACADIA Pharmaceuticals announced that the FDA granted Fast Track designation to remlifanserin, its investigational 5-HT2A inverse agonist for hallucinations and delusions in Alzheimer’s disease psychosis, alongside progress updates on the seamless Phase 2/3 RADIANT program. This designation, coupled with ongoing Phase 3 enrollment, highlights how remlifanserin could meaningfully expand ACADIA’s late-stage CNS portfolio beyond its current commercial drugs. Next, we’ll...

Uber Technologies has given investors a solid 56.8% return over the past five years, yet the stock has recently pulled back and now screens as undervalued on several key checks, putting fresh focus on whether the current price still reflects the underlying business. Over five years, Uber Technologies has returned 56.8%, which puts the recent share price weakness into context as part of a longer period of positive performance. New partnerships such as the GameStop delivery tie up and...

Tandem Diabetes Care (TNDM) stock has drawn attention after recent trading left it at a last close of $17.17, prompting investors to reassess its performance over the past month and past 3 months. See our latest analysis for Tandem Diabetes Care. At a share price of $17.17, Tandem Diabetes Care has seen a modest 30 day share price return of 5.73%. However, its year to date share price return is down 20.32%, and the 3 year total shareholder return is down 50.83%. This points to fading momentum...

Marvell Technology’s share price has delivered a very strong 218.2% return over the past 5 years, yet its valuation signals are split, with the Discounted Cash Flow (DCF) intrinsic value pointing to a premium to current cash flow assumptions while market multiples still screen the stock as relatively inexpensive against peers. Over 5 years, Marvell Technology has returned 218.2%, which puts extra focus on whether today’s price is already baking in optimistic expectations. Recent enthusiasm...

Karman Holdings (NYSE:KRMN) is investing $2.7 million to expand its Horsham, Pa. facility. The expansion is intended to support advanced defense material technologies and US Navy operational readiness. The project is aligned with recent acquisitions and is expected to increase production capacity and high tech employment at the site. Karman Holdings operates in advanced materials and defense related technologies, a segment that sits at the intersection of national security priorities and...

Snowflake stock sits at the center of a clear valuation tension, with the intrinsic value estimate from a Discounted Cash Flow (DCF) model pointing to roughly 41.0% upside relative to the market price, while market based multiples lean the other way and the broader checks flag the shares as far from a straightforward bargain. Snowflake has returned 53.6% over the past 3 years, which puts extra weight on whether current buyers are paying a premium for that track record. Recent AI focused...

Dime Commercial Bancshares, Inc. reported its second-quarter 2026 results with net interest income of US$115.19 million and net income of US$34.81 million, both higher than a year earlier, while also declaring a quarterly US$0.34375 dividend on its 5.50% Series A preferred stock payable on August 14, 2026. The combination of stronger core earnings and the continuation of preferred dividends highlights the bank’s capacity to support income-focused investors while reinforcing its capital...

With inflation, energy prices and central banks all pulling on your portfolio at once, steady dividend income can feel more valuable than ever. That is where Dividend Powerhouses with 5%+ yields and a track record of well covered, growing and stable payouts come in. This screener focuses on companies that put cash returns to shareholders at the centre of their story. This can help balance choppy markets and mixed growth signals across regions. In this article, you will see 3 of the strongest...

The new content partnership between NBCUniversal’s Peacock and YouTube Premium has pushed streaming distribution into fresh territory, and investors in digital entertainment are watching closely. By folding Peacock’s full library, including NFL and NBA rights, into YouTube Premium from early 2027, the deal links one of the largest video platforms with a growing subscription service. It also points to new ways of sharing content, advertising, and revenue across platforms. This article walks...

Earlier this week, Biohaven disclosed that a federal jury awarded the company US$1,000,000 in damages in a trade secret lawsuit against Avilar Therapeutics and RA Capital Management. The verdict underscores the legal weight behind Biohaven’s efforts to safeguard its intellectual property, a core asset for any research‑driven biopharmaceutical business. Next, we’ll examine how this courtroom win on intellectual property protection shapes Biohaven’s broader investment narrative over the coming...